BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1917429)

  • 1. Thromboblastic hyperthyroidism: sensitive monoclonal TSH assay demonstrates suppressed immunoreactive TSH.
    Abuaisha B; Barrett E; O'Hare J
    Ir J Med Sci; 1991 Mar; 160(3):96-7. PubMed ID: 1917429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete mole with a false-low level of human chorionic gonadotropin and hyperthyroidism.
    Henriksen R; Opheim GL; Saltrøe E
    Acta Obstet Gynecol Scand; 2007; 86(5):633-5. PubMed ID: 17464597
    [No Abstract]   [Full Text] [Related]  

  • 3. [Uterine tumor, HCG excess and hyperthyroidism in a 51-year old woman].
    Mödl BM; Nentwich K; Hitzler HJ; Lorch R; Keller E; Pfafferott C
    Internist (Berl); 2001 Mar; 42(3):411-5. PubMed ID: 11277025
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
    Ngowngarmratana S; Sunthornthepvarakul T; Kanchanawat S
    J Med Assoc Thai; 1997 Nov; 80(11):693-9. PubMed ID: 9385765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
    Kato K; Mostafa MH; Mann K; Schindler AE; Hoermann R
    Gynecol Endocrinol; 2004 May; 18(5):269-77. PubMed ID: 15346663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperthyroidism induced by molar pregnancy].
    Laurent V; Besson L; Doussin JF; Rondelet B; Banssillon V
    Ann Fr Anesth Reanim; 1993; 12(4):424-7. PubMed ID: 8273931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay].
    Hara H; Ban Y; Sato R; Nagakura H; Kushima K; Kaihara M; Matsuzaki H
    Kaku Igaku; 1988 Jan; 25(1):89-96. PubMed ID: 3373811
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthyroidism in gestational trophoblastic neoplasia.
    Norman RJ; Green-Thompson RW; Jialal I; Soutter WP; Pillay NL; Joubert SM
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):395-401. PubMed ID: 7318191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism and a negative urine hCG test in molar pregnancy.
    Kazemi MR; Vargas JE; Lo JC
    Am J Med; 2004 Dec; 117(11):889-90. PubMed ID: 15589502
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased in vitro thyrotropic activity of partially sialated human chorionic gonadotropin extracted from hydatidiform moles of patients with hyperthyroidism.
    Pekary AE; Jackson IM; Goodwin TM; Pang XP; Hein MD; Hershman JM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):70-4. PubMed ID: 8421106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A T2S cross-reactive material (compound W) in hyperthyroid patients with trophoblastic disease.
    Rajatanavin R; Fisher DA; Chailurkit L; Huang WS; Srisupandit S; Wu SY
    Thyroid; 1999 Oct; 9(10):989-94. PubMed ID: 10560952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyrotoxicosis of hydatidiform mole.
    Higgins HP; Hershman JM; Kenimer JG; Patillo RA; Bayley TA; Walfish P
    Ann Intern Med; 1975 Sep; 83(3):307-11. PubMed ID: 1180425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to human chorionic gonadotropin (HCG) and their use in two-site binding enzyme immunoassays.
    Böttger V; Micheel B; Scharte G; Kaiser G; Wolf G; Schmechta H
    Hybridoma; 1993 Feb; 12(1):81-91. PubMed ID: 7681037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient hyperthyroidism in an adolescent with hydatidiform mole.
    Misra M; Levitsky LL; Lee MM
    J Pediatr; 2002 Mar; 140(3):362-6. PubMed ID: 11953736
    [No Abstract]   [Full Text] [Related]  

  • 15. An unusual cause of cardiothyreosis.
    Marchand L; Chabert P; Chaudesaygues E; Grasse M; Bretones S; Graeppi-Dulac J; Aupetit JF
    Gynecol Endocrinol; 2016; 32(2):107-9. PubMed ID: 26559442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated intravesicular fluid thyroid-stimulating hormone concentration in hydatidiform mole.
    Gunasegaram R; Peh KL; Loganath A; Kottegoda SR; Ratnam SS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):177-81. PubMed ID: 2434371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.
    Lockwood CM; Grenache DG; Gronowski AM
    Thyroid; 2009 Aug; 19(8):863-8. PubMed ID: 19505185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors.
    Hershman JM
    Thyroid; 1999 Jul; 9(7):653-7. PubMed ID: 10447009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
    Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
    Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthyroidism secondary to a hydatidiform mole.
    Grzechocinska B; Gajewska M; Kedzierski M; Gajda S; Jedrzejak P; Wielgos M
    Ginekol Pol; 2021; 92(10):741-742. PubMed ID: 34747003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.